A detailed history of Hantz Financial Services, Inc. transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 40 shares of TNDM stock, worth $613. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Previous 35 14.29%
Holding current value
$613
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 04, 2025

BUY
$16.35 - $23.52 $81 - $117
5 Added 14.29%
40 $1,000
Q1 2025

May 12, 2025

BUY
$17.89 - $37.53 $626 - $1,313
35 New
35 $1,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $985M
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.